Who are Quinvaxem in Uniject's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Quinvaxem in single dose vials.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/quinvaxem-in-uniject.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Quinvaxem in Uniject — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quinvaxem in Uniject (Quinvaxem in Uniject) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Pentavalent conjugate vaccine. Area: Immunology.

phase 3 Pentavalent conjugate vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Quinvaxem in Uniject (Quinvaxem in Uniject) — Crucell Holland BV. Quinvaxem is a pentavalent conjugate vaccine that provides immunization against Haemophilus influenzae type b, diphtheria, tetanus, pertussis, and hepatitis B through stimulation of humoral and cellular immune responses.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Quinvaxem in Uniject TARGET	Quinvaxem in Uniject	Crucell Holland BV	phase 3	Pentavalent conjugate vaccine
Quinvaxem in single dose vials	Quinvaxem in single dose vials	Crucell Holland BV	phase 3	Pentavalent conjugate vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Pentavalent conjugate vaccine class)

Crucell Holland BV · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Quinvaxem in Uniject — Competitive Intelligence Brief. https://druglandscape.com/ci/quinvaxem-in-uniject. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing